What Are the Key Nursing Considerations for Bone Marrow Suppression Following Chemotherapy?

Most chemotherapy drugs cause myelosuppression as a side effect. Myelosuppression primarily manifests as abnormalities in routine blood tests, most commonly decreased white blood cell (WBC) and platelet counts. It typically occurs after chemotherapy administration, with WBC decline usually appearing first. Because platelets have a relatively long lifespan, thrombocytopenia tends to develop later.

Key Nursing Considerations for Chemotherapy-Induced Myelosuppression

1. White Blood Cells (WBCs)

WBCs play a critical role in defending the body against external infections. Thus, patients experiencing neutropenia (low WBC count) have diminished infection resistance compared to healthy individuals. During this period, special attention should be paid to diet and daily activities—for example, ensuring food is clean and hygienic. Additionally, wearing a mask when going outdoors helps reduce infection risk.

2. Red Blood Cells (RBCs)

RBCs are essential for oxygen transport. Therefore, anemia—characterized by reduced RBC count—commonly leads to symptoms such as fatigue and shortness of breath upon exertion. Patients with anemia should limit physical activity to reduce the body’s oxygen demand, which can help alleviate symptoms. Additionally, consuming iron-rich foods—including jujubes (Chinese dates) and meats—is recommended.

3. Platelets

Platelets are vital for normal hemostasis. Consequently, thrombocytopenia increases bleeding risk. The most common manifestations involve mucocutaneous bleeding—such as gingival or nasal bleeding—and even spontaneous bruising following minor trauma. For these patients, maintaining oral mucosal moisture is important, and precautions should be taken to avoid injury. Drinking decoctions made from red peanut skins may also support platelet recovery.

The above outlines key nursing considerations for managing chemotherapy-induced myelosuppression. We hope this information is helpful to you.